Dr. Catherine Bollard is an award-winning senior scientist in the Center for Cancer and Immunology Research at the Children’s Research Institute, a member of the Division of the Blood and Marrow Transplantation, and the Principal Investigator and Co-Director of the Immunology Initiative of the Sheikh Zayed Institute for Pediatric Surgical Innovation. In this role, she leads clinical and research efforts to fight cancer and other inflammatory diseases by strengthening a child’s immune system. As the current President of the International Society of Cellular Therapy, she is a distinguished hematologist and immunotherapist, working to develop cell and gene therapies for patients with cancer and underlying immune deficiencies.
Additionally, Dr. Bollard is interested in stem cell and cord blood transplantation, and improving outcomes by decreasing infectious complications and preventing relapse. She also has a specific interest in targeting viral infections in the immune suppression population, including individuals living with HIV. Further, building on her focus developing cell therapies for EBV-associated lymphomas and as head of the NHL committee of the Children’s Oncology Group, she has moved T-cell therapies to the cooperative group setting.
As a national and international leader in the immunology and immunotherapy space, Dr. Bollard’s work expands our understanding of cancer in pediatric patients. She joined Children’s National from the Baylor College of Medicine where she was a tenured Professor in the Department of Pediatrics. Prior to that, she served as a Postdoctoral Fellow at Texas Children’s Hospital. Dr. Bollard received her medical degree from Otago University Medical School in New Zealand.
University of Otago